帕金森病的肠道菌群标志物研究进展

doi:10.3969/j.issn.1006-5725.2024.11.001

Abstract

Abstract:

Parkinson's disease （PD） challenges us to assess the disease due to the lack of definitive biomarkers. Currently， PD patients have been found to contract several gastrointestinal comorbidities such as constipation and intestinal inflammation that precede its symptomatic manifestations. These conditions are intricately linked to proliferative metabolisms of the gut microbiota， which are manifested to be some primary changes in the gut microbiota or other changes involved in medication during treatment. In this paper we review the recent research on gut microbiota biomarkers in PD， arguing for the clinical relevance of gut microbiota as a marker in the progression of PD and prospecting the potential efficacy of fecal microbiota transplantation as an intervention in managing PD.

Key words: Parkinson's disease, intestinal flora, markers

CLC Number:

R741.02

Yanwei HUANG,Kaitai ZENG,Ziqi WEN,Yan LI,Rongping. CHEN. Markers of gut flora in Parkinson′s disease： A literature review[J]. The Journal of Practical Medicine, 2024, 40(11): 1473-1478.

References 44

1	AHO V T E， HOUSER M C， PEREIRA P A B， et al. Relationships of gut microbiota， short-chain fatty acids， inflammation， and the gut barrier in Parkinson′s disease.［J］. Mol Neurodegener，2021， 16（1）： 6. doi:10.1186/s13024-021-00427-6 doi: 10.1186/s13024-021-00427-6
2	CHEN S J， CHEN C C， LIAO H Y， et al. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.［J］. Neurologys，2022， 98（8）： e848-e858. doi:10.1212/wnl.0000000000013225 doi: 10.1212/wnl.0000000000013225
3	ZHANG X， TANG B， GUO J. Parkinson′s disease and gut microbiota： from clinical to mechanistic and therapeutic studies［J］. Transl Neurodegener， 2023， 12（1）： 59. doi:10.1186/s40035-023-00392-8 doi: 10.1186/s40035-023-00392-8
4	AHO V T E， PEREIRA P A B， VOUTILAINEN S， et al. Gut microbiota in Parkinson′s disease： Temporal stability and relations to disease progression［J］. EBioMedicine，2019， 44： 691-707. doi:10.1016/j.ebiom.2019.05.064 doi: 10.1016/j.ebiom.2019.05.064
5	HUH E， CHOI J G， CHOI Y， et al. P. mirabilis-derived pore-forming haemolysin， HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration［J］. EBioMedicine， 2023， 98： 104887. doi:10.1016/j.ebiom.2023.104887 doi: 10.1016/j.ebiom.2023.104887
6	黄东泉，郑文霞，谢惠芳，等. 帕金森病患者肠道嗜黏蛋白阿克曼菌各亚型丰度的变化及其临床价值［J］. 实用医学杂志， 2020， 36（12）： 1673-1678. doi:10.3969/j.issn.1006-5725.2020.12.025 doi: 10.3969/j.issn.1006-5725.2020.12.025
7	LIN C H， CHEN C C， CHIANG H L， et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson′s disease［J］. J Neuroinflammation，2019， 16（1）： 129. doi:10.1186/s12974-019-1528-y doi: 10.1186/s12974-019-1528-y
8	BRAAK H， DEL TREDICI K， RÜB U， et al. Staging of brain pathology related to sporadic Parkinson′s disease［J］. Neurobiol Aging， 2003， 24（2）： 197-211. doi:10.1016/s0197-4580(02)00065-9 doi: 10.1016/s0197-4580(02)00065-9
9	CHANDRA R， SOKRATIAN A， CHAVEZ K R， et al. Gut mucosal cells transfer α-synuclein to the vagus nerve［J］. JCI Insight， 2023， 8（23）： e172192. doi:10.1172/jci.insight.172192 doi: 10.1172/jci.insight.172192
10	KIM S， KWON S H， KAM T I， et al. Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson′s Disease［J］. Neuron， 2019， 103（4）： 627-641.e7. doi:10.1016/j.neuron.2019.05.035 doi: 10.1016/j.neuron.2019.05.035
11	KILLINGER B A， MADAJ Z， SIKORA J W， et al. The vermiform appendix impacts the risk of developing Parkinson′s disease［J］. Sci Transl Med， 2018， 10（465）： eaar5280. doi:10.1126/scitranslmed.aar5280 doi: 10.1126/scitranslmed.aar5280
12	GOYA M E， XUE F， SAMPEDRO-TORRES-QUEVEDO C， et al. Probiotic Bacillus subtilis Protects against α-Synuclein Aggregation in C. elegans［J］. Cell Rep，2020， 30（2）： 367-380.e7. doi:10.1016/j.celrep.2019.12.078 doi: 10.1016/j.celrep.2019.12.078
13	徐晓峰，罗汉将，莫琼，等. 异常增加的α-突触核蛋白对帕金森病模型小鼠黑质及结肠多巴胺受体D1的表达影响［J］. 实用医学杂志， 2021， 37（9）： 1106-1110，1116. doi:10.3969/j.issn.1006-5725.2021.09.002 doi: 10.3969/j.issn.1006-5725.2021.09.002
14	ALIFIROVA V M， ZHUKOVA N G， ZHUKOVA I A， et al. Correlation Between Emotional-Affective Disorders and Gut Microbiota Composition in Patients with Parkinson′s Disease［J］. Vestn Ross Akad Med Nauk，2016， 71（6）： 427-435.
15	FU S C， SHIH L C， WU P H， et al. Exploring the Causal Effect of Constipation on Parkinson′s Disease Through Mediation Analysis of Microbial Data［J］. Front Cell Infect Microbiol，2022， 12： 871710. doi:10.3389/fcimb.2022.871710 doi: 10.3389/fcimb.2022.871710
16	李淑华，陈海波. 我国近十年帕金森病研究进展回顾与展望［J］. 中国神经免疫学和神经病学杂志， 2023， 30（1）： 3-9.
17	HEINTZ-BUSCHART A， PANDEY U， WICKE T， et al. The nasal and gut microbiome in Parkinson′s disease and idiopathic rapid eye movement sleep behavior disorder［J］. Mov Disord，2018， 33（1）： 88-98. doi:10.1002/mds.27105 doi: 10.1002/mds.27105
18	张卓尔，高筱雅，余娟，等. lncRNA KCNQ1OT1靶向miR-129-5p调控帕金森病细胞模型炎症和细胞凋亡的实验研究［J］. 实用医学杂志， 2023， 39（6）： 672-678. doi:10.3969/j.issn.1006-5725.2023.06.004 doi: 10.3969/j.issn.1006-5725.2023.06.004
19	DODIYA H B， FORSYTH C B， VOIGT R M， et al. Chronic stress-induced gut dysfunction exacerbates Parkinson′s disease phenotype and pathology in a rotenone-induced mouse model of Parkinson′s disease［J］. Neurobiol Dis， 2020， 135： 104352. doi:10.1016/j.nbd.2018.12.012 doi: 10.1016/j.nbd.2018.12.012
20	VOIGT R M， WANG Z， BROWN J M， et al. Gut microbial metabolites in Parkinson′s disease： Association with lifestyle， disease characteristics， and treatment status［J］. Neurobiol Dis， 2022， 170： 105780. doi:10.1016/j.nbd.2022.105780 doi: 10.1016/j.nbd.2022.105780
21	LI J， MENG P， ZHANG J， et al. Effect of Berberine Hydrochloride on the Diversity of Intestinal Flora in Parkinson′s Disease Patients［J］. Contrast Media Mol Imaging，2022， 2022： 8381870. doi:10.1155/2022/8381870 doi: 10.1155/2022/8381870
22	ROSARIO D， BIDKHORI G， LEE S， et al. Systematic analysis of gut microbiome reveals the role of bacterial folate and homocysteine metabolism in Parkinson′s disease［J］. Cell Rep，2021， 34（9）： 108807. doi:10.1016/j.celrep.2021.108807 doi: 10.1016/j.celrep.2021.108807
23	BALDINI F， HERTEL J， SANDT E， et al. Parkinson′s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions［J］. BMC Biol，2020， 18（1）： 62.
24	HERTEL J， HARMS A C， HEINKEN A， et al. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson′s Disease［J］. Cell Rep， 2019， 29（7）： 1767-1777.e8. doi:10.1016/j.celrep.2019.10.035 doi: 10.1016/j.celrep.2019.10.035
25	GUO X， SONG W， CHEN K， et al. The serum lipid profile of Parkinson′s disease patients： a study from China［J］. Int J Neurosci， 2015， 125（11）： 838-844. doi:10.3109/00207454.2014.979288 doi: 10.3109/00207454.2014.979288
26	TRABJERG M S， ANDERSEN D C， HUNTJENS P， et al. Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS［J］. Commun Biol， 2021， 4（1）： 509. doi:10.1038/s42003-021-02034-z doi: 10.1038/s42003-021-02034-z
27	刘梓嘉，姜雪，仪杨，等. 氢气与肠道菌群的关系研究进展［J］. 生物技术进展， 2022， 12（6）： 847-852.
28	杨文学，李敏，李明伟，等. 氨代谢紊乱与帕金森病相关性研究［J］. 空军军医大学学报， 2023，44（10）： 1002-1010.
29	NIXON A M， MEADOWCROFT M D， NEELY E B， et al. HFE Genotype Restricts the Response to Paraquat in a Mouse Model of Neurotoxicity［J］. J Neurochem，2018， 145（4）： 299-311. doi:10.1111/jnc.14299 doi: 10.1111/jnc.14299
30	SINGH Y， TRAUTWEIN C， DHARIWAL A， et al. DJ-1 （Park7） affects the gut microbiome， metabolites and the development of innate lymphoid cells （ILCs）［J］. Sci Rep， 2020， 10（1）： 16131. doi:10.1038/s41598-020-72903-w doi: 10.1038/s41598-020-72903-w
31	MINATO T， MAEDA T， FUJISAWA Y， et al. Progression of Parkinson′s disease is associated with gut dysbiosis： Two-year follow-up study.［J］. PLoS One， 2017， 12（11）： e0187307. doi:10.1371/journal.pone.0187307 doi: 10.1371/journal.pone.0187307
32	GARDAI S J， MAO W， SCHÜLE B， et al. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson′s disease［J］. PLoS One， 2013， 8（8）： e71634. doi:10.1371/journal.pone.0071634 doi: 10.1371/journal.pone.0071634
33	LIANG D， LIU H， JIN R， et al. Escherichia coli triggers α- synuclein pathology in the LRRK2 transgenic mouse model of PD［J］. Gut Microbes， 2023， 15（2）： 2276296. doi:10.1080/19490976.2023.2276296 doi: 10.1080/19490976.2023.2276296
34	XIE A， ENSINK E， LI P， et al. Bacterial Butyrate in Parkinson′s Disease Is Linked to Epigenetic Changes and Depressive Symptoms［J］. Mov Disord，2022， 37（8）： 1644-1653. doi:10.1002/mds.29128 doi: 10.1002/mds.29128
35	HACKER M L， DELONG M R， TURCHAN M，et al. Effects of deep brain stimulation on rest tremor progression in early stage Parkinson disease［J］. Neurology， 2018， 91（5）：e463-e471. doi:10.1212/wnl.0000000000005903 doi: 10.1212/wnl.0000000000005903
36	BOUTET A， CHOW C T， NARANG K， et al. Improving Safety of MRI in Patients with Deep Brain Stimulation Devices［J］. Radiology， 2020， 296（2）： 250-262. doi:10.1148/radiol.2020192291 doi: 10.1148/radiol.2020192291
37	VAN KESSEL S P， FRYE A K， EL-GENDY A O， et al. Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson′s disease［J］. Nat Commun，2019， 10（1）： 310. doi:10.1038/s41467-019-08294-y doi: 10.1038/s41467-019-08294-y
38	FU S C， LEE C H， HSIEH Y C， et al. A Pilot Study Exploring the Association of Entacapone， Gut Microbiota， and the Subsequent Side Effects in Patients With Parkinson′s Disease［J］. Front Cell Infect Microbiol， 2022， 12： 837019. doi:10.3389/fcimb.2022.837019 doi: 10.3389/fcimb.2022.837019
39	YI M， CHEN R P， YANG R， et al. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China［J］. Diabet Med， 2017， 34（4）： 505-513. doi:10.1111/dme.13174 doi: 10.1111/dme.13174
40	张艺，许宁宁，彭子翀，等. 粪菌移植通过微生物-肠-脑轴改善抑郁症的研究进展［J］. 微生物学通报， 2022， 49（2）： 756-768.
41	ZHAO Z， NING J， BAO X Q， et al. Fecal microbiota transplantation protects rotenone-induced Parkinson′s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis［J］. Microbiome，2021，9（1）：226. doi:10.1186/s40168-021-01107-9 doi: 10.1186/s40168-021-01107-9
42	HEGELMAIER T， LEBBING M， DUSCHA A， et al. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson′s Disease［J］. Cells， 2020， 9（2）：376. doi:10.3390/cells9020376 doi: 10.3390/cells9020376
43	KUAI X Y， YAO X H， XU L J， et al. Evaluation of fecal microbiota transplantation in Parkinson′s disease patients with constipation［J］. Microb Cell Fact，2021， 20（1）： 98. doi:10.1186/s12934-021-01589-0 doi: 10.1186/s12934-021-01589-0
44	IBRAHIM A， ALI R A R， MANAF M R A， et al. Multi-strain probiotics （Hexbio） containing MCP BCMC strains improved constipation and gut motility in Parkinson′s disease： A randomised controlled trial.［J］. PLoS One， 2020， 15（12）： e0244680. doi:10.1371/journal.pone.0244680 doi: 10.1371/journal.pone.0244680

[1]	Shaojin LI,Shipeng. ZHENG. Relevant preoperative imaging pathological features and tumor markers serve as predictive indicators for the risk of sentinel lymph node metastasis in breast cancer [J]. The Journal of Practical Medicine, 2024, 40(17): 2418-2424.
[2]	Kaming YANG,Zhenlin LI,Wanwen LAO,Aixia ZHAI,Changlong. BI. Serological biomarkers for diagnosis of diabetes foot： A review of literature [J]. The Journal of Practical Medicine, 2024, 40(16): 2224-2228.
[3]	Nan LI,Xue ZHAO, A′nali,Heran LIANG,Na. GE. Research progress on the role of bile acids in alcoholic liver disease [J]. The Journal of Practical Medicine, 2024, 40(15): 2187-2193.
[4]	Jie YANG,Chunhong LI,Jingfei HUANG,Zhiwei CHEN,Lin. LIU. The expression and clinical significance of hsa_circ_0003922 in endometrioid carcinoma [J]. The Journal of Practical Medicine, 2024, 40(14): 1975-1980.
[5]	Kexin XI,Yuqi ZHAO,Xiaoting XIE,Yuntao LU,Hongying FAN,Xiaoyan. HE. Research progress on the regulation of intestinal flora on glioma [J]. The Journal of Practical Medicine, 2024, 40(14): 2027-2030.
[6]	Shuhong RUI,Chenfang WANG,Yunhe LI,Junlan PAN,Jianlou WANG. Effects of indobuprofen combined with nicodil on inflammatory factors， myocardial injury markers and platelet function in patients with ACS after PCI [J]. The Journal of Practical Medicine, 2024, 40(12): 1706-1711.
[7]	Chunling PAN,Xueli YI,Li SU,Shengshan YUAN,Guijiang WEI. Research progress of circrna and atherosclerotic ischemic stroke [J]. The Journal of Practical Medicine, 2024, 40(12): 1755-1761.
[8]	Xinwen BI,Yuanjie CUI,Qiuxian LU,Jia CUI,Fan BU,Fang HE,Hua YANG,Ming. LI. Immunomodulatory effects of intestinal flora on glucose and lipid metabolism disorders in high⁃fat diet induced obese mice [J]. The Journal of Practical Medicine, 2024, 40(11): 1505-1512.
[9]	Jie SHEN,Guihua. XU. Research progress in the relationship between Alzheimer′s disease and blood⁃brain barrier [J]. The Journal of Practical Medicine, 2024, 40(11): 1602-1606.
[10]	ZHANG Jianqing, WANG Qing, JIANG Kehua, SUN Fa.. The role of microRNAs in kidney stone disease：a literature review [J]. The Journal of Practical Medicine, 2023, 39(6): 773-777.
[11]	Jun DENG,Jun WANG,Chang′e GAO,Xiao CHEN,Mingxia. SHI. Research progress of predictive biomarkers for immune⁃related adverse events [J]. The Journal of Practical Medicine, 2023, 39(20): 2561-2565.
[12]	Ming LI,Wei SU,Shiheng. MA. Analyze of the value of bifidum in the treatment of sepsis caused by pulmonary infection based on intestinal immunity [J]. The Journal of Practical Medicine, 2023, 39(18): 2384-2388.
[13]	Hua PAN,Minshang ZHANG,Xu WANG,Dandan. JIANG. Effect of Qi Chang Xue Xing Tang retention enema combined with heat sensitive moxibustion on gastrointestinal function and immune function of patients after radical gastrectomy [J]. The Journal of Practical Medicine, 2023, 39(16): 2130-2135.
[14]	DUAN Ruixue, YANG Bin, XIA Tianhong, YAN Long, LIANG Xiaoqin, LIU Hongbin. . Expression and diagnostic value of plasma exosome PD ⁃L1 in gastric cancer [J]. The Journal of Practical Medicine, 2023, 39(13): 1698-1703.
[15]	LEI Yu, HU Yaxin, YU Lei, CHENG Mingliang, CHENG Zhuo, CONG Shuo, PU Qian, ZHENG Lin. . Effect of intrahepatic cholestasis on bile acid spectrum and intestinal flora in ileocecum of mice [J]. The Journal of Practical Medicine, 2023, 39(10): 1232-1236.

Markers of gut flora in Parkinson′s disease： A literature review

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 44

Related Articles 15

Recommended Articles

Metrics

Comments